PCM
ETRM

Potomac Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Potomac Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-161
Closed -$307K – 96
2014
Q1 		$307K Buy
+161
New +$381K 0.26% 57

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Potomac Capital Management's ETRM Position: Q2 2014 in Review

Potomac Capital Management sold out of EnteroMedics Inc. (ETRM) in Q2 2014, closing a stake of 161 shares — an estimated $307K sold.

Potomac Capital Management first reported a position in ETRM in Q1 2014 and held it in 1 quarter. The position peaked at $307K in Q1 2014. 56 funds tracked by Wall St. Rank hold ETRM as of Q2 2014.

  • Potomac Capital Management reported no remaining EnteroMedics Inc. position as of Q2 2014 after selling out during the quarter.
  • Potomac Capital Management sold 161 EnteroMedics Inc. shares in Q2 2014, an estimated $307K.
  • Potomac Capital Management first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 1 quarter.
  • Potomac Capital Management's EnteroMedics Inc. position peaked at $307K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2014.

Based on Potomac Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.